SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001171843-19-004740
Filing Date
2019-07-24
Accepted
2019-07-24 07:03:14
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM F-3 f3_072419.htm F-3 286808
2 EXHIBIT 5.1 exh_51.htm EX-5.1 25717
3 EXHIBIT 23.1 exh_231.htm EX-23.1 3297
4 GRAPHIC logo.jpg GRAPHIC 12221
5 GRAPHIC gkh.jpg GRAPHIC 7864
6 GRAPHIC pwc.jpg GRAPHIC 2314
  Complete submission text file 0001171843-19-004740.txt   347958
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: F-3 | Act: 33 | File No.: 333-232777 | Film No.: 19969197
SIC: 2834 Pharmaceutical Preparations